搜索临床试验以:曲马多缓释片
总计1042个结果
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen, LP完全的分裂情感障碍 | 精神障碍美国, 印度, 马来西亚, 罗马尼亚, 大韩民国, 菲律宾
-
Johnson & Johnson Pharmaceutical Research & Development...完全的
-
Johnson & Johnson Pharmaceutical Research & Development...Grünenthal GmbH完全的
-
Johnson & Johnson Pharmaceutical Research & Development...完全的躁郁症 | 狂躁 | 情感性精神病,双相
-
National Cancer Institute (NCI)主动,不招人解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 转移性三阴性乳腺癌 | 不可切除的三阴性乳腺癌美国
-
Indiana University School of MedicineOrtho-McNeil Janssen Scientific Affairs, LLC完全的
-
Johnson & Johnson Pharmaceutical Research & Development...完全的
-
Johnson & Johnson Pharmaceutical Research & Development...Grünenthal GmbH完全的
-
Johnson & Johnson Taiwan Ltd完全的
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen, LP完全的分裂情感障碍 | 精神障碍
-
Johnson & Johnson Pharmaceutical Research & Development...完全的
-
Johnson & Johnson Pharmaceutical Research & Development...完全的
-
Johnson & Johnson Pharmaceutical Research & Development...完全的
-
Medical University of SilesiaSilesian University of Medicine完全的
-
Johnson & Johnson Pharmaceutical Research & Development...完全的
-
Medecins Sans Frontieres, NetherlandsLondon School of Hygiene and Tropical Medicine; University of Sussex; Ministry of Health, Republic... 和其他合作者完全的
-
University of California, Los AngelesMayo Clinic; Hacettepe University; All India Institute of Medical Sciences, New Delhi; University... 和其他合作者完全的
-
University of Sao PauloUniversity of Sao Paulo General Hospital完全的
-
Johnson & Johnson Pharmaceutical Research & Development...完全的
-
Taipei City HospitalJohnson & Johnson Taiwan Ltd; Taipei Institute of Pathology完全的
-
Johnson & Johnson Pharmaceutical Research & Development...完全的
-
Janssen-Cilag Turkey完全的
-
Chonnam National University HospitalJanssen Korea, Ltd., Korea; Ministry of Health, Republic of Korea完全的
-
Johnson & Johnson Pharmaceutical Research & Development...完全的
-
Mark EisenbergCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada完全的心肌梗塞 | 抽烟 | 急性冠状动脉综合征加拿大, 美国, 孟加拉国, 印度, 伊朗伊斯兰共和国, 巴基斯坦, 突尼斯
-
Janssen-Cilag G.m.b.H终止
-
GlaxoSmithKline终止